Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Berger

Showing results (181-190 of 275) with videos related to

Pageof 28
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|November 6, 2009
Immunostimulatory RNA oligonucleotides induce an effective antitumoral NK cell response through the TLR7Carole Bourquin, Laura Schmidt, Anna-Lisa Lanz, et al.
Plos One|August 15, 2015
Phase II Trial of Sorafenib in Patients with Chemotherapy Refractory Metastatic Esophageal and Gastroesophageal (GE) Junction CancerYelena Y Janjigian, Efsevia Vakiani, Geoffrey Y Ku, et al.
The Journal of Clinical Investigation|April 13, 2021
Myeloid cell-derived PROS1 inhibits tumor metastasis by regulating inflammatory and immune responses via IL-10Avi Maimon, Victor Levi-Yahid, Kerem Ben-Meir, et al.
Microsurgery|February 17, 2025
Early Feeding After Free Flap Reconstruction for Oral Cavity Cancer: A Single Institution Retrospective ReviewJoshua Barlow, Christine Little, Susmita Chennareddy, et al.
Journal of Medicinal Chemistry|April 7, 2016
Discovery and Structure-Activity Relationships of the Neoseptins: A New Class of Toll-like Receptor-4 (TLR4) AgonistsMatthew D Morin, Ying Wang, Brian T Jones, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2009
Selection of molecular structure and delivery of RNA oligonucleotides to activate TLR7 versus TLR8 and to induce high amounts of IL-12p70 in primary human monocytesAndrea Ablasser, Hendrik Poeck, David Anz, et al.
Current Oncology (Toronto, Ont.)|January 20, 2022
The Neurokinin-1 Receptor Is a Target in Pediatric Rhabdoid TumorsJulian Kolorz, Salih Demir, Adrian Gottschlich, et al.
Nature Communications|May 9, 2025
Metabolic reprogramming driven by Ant2 deficiency augments T Cell function and anti-tumor immunity in miceOmri Yosef, Leonor Cohen-Daniel, Oded Shamriz, et al.
Frontiers in Behavioral Neuroscience|September 9, 2015
The effect of modafinil on the rat dopamine transporter and dopamine receptors D1-D3 paralleling cognitive enhancement in the radial arm mazeYasemin Karabacak, Sunetra Sase, Yogesh D Aher, et al.
Medrxiv : the Preprint Server for Health Sciences|September 21, 2023
Deep Learning Model for Tumor Type Prediction using Targeted Clinical Genomic Sequencing DataMadison Darmofal, Shalabh Suman, Gurnit Atwal, et al.
Pageof 28

Showing results (181-190 of 275) with videos related to

Sort By:
Pageof 28
Journal of Immunology (Baltimore, Md. : 1950)|November 6, 2009
Immunostimulatory RNA oligonucleotides induce an effective antitumoral NK cell response through the TLR7Carole Bourquin, Laura Schmidt, Anna-Lisa Lanz, et al.
Plos One|August 15, 2015
Phase II Trial of Sorafenib in Patients with Chemotherapy Refractory Metastatic Esophageal and Gastroesophageal (GE) Junction CancerYelena Y Janjigian, Efsevia Vakiani, Geoffrey Y Ku, et al.
The Journal of Clinical Investigation|April 13, 2021
Myeloid cell-derived PROS1 inhibits tumor metastasis by regulating inflammatory and immune responses via IL-10Avi Maimon, Victor Levi-Yahid, Kerem Ben-Meir, et al.
Microsurgery|February 17, 2025
Early Feeding After Free Flap Reconstruction for Oral Cavity Cancer: A Single Institution Retrospective ReviewJoshua Barlow, Christine Little, Susmita Chennareddy, et al.
Journal of Medicinal Chemistry|April 7, 2016
Discovery and Structure-Activity Relationships of the Neoseptins: A New Class of Toll-like Receptor-4 (TLR4) AgonistsMatthew D Morin, Ying Wang, Brian T Jones, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2009
Selection of molecular structure and delivery of RNA oligonucleotides to activate TLR7 versus TLR8 and to induce high amounts of IL-12p70 in primary human monocytesAndrea Ablasser, Hendrik Poeck, David Anz, et al.
Current Oncology (Toronto, Ont.)|January 20, 2022
The Neurokinin-1 Receptor Is a Target in Pediatric Rhabdoid TumorsJulian Kolorz, Salih Demir, Adrian Gottschlich, et al.
Nature Communications|May 9, 2025
Metabolic reprogramming driven by Ant2 deficiency augments T Cell function and anti-tumor immunity in miceOmri Yosef, Leonor Cohen-Daniel, Oded Shamriz, et al.
Frontiers in Behavioral Neuroscience|September 9, 2015
The effect of modafinil on the rat dopamine transporter and dopamine receptors D1-D3 paralleling cognitive enhancement in the radial arm mazeYasemin Karabacak, Sunetra Sase, Yogesh D Aher, et al.
Medrxiv : the Preprint Server for Health Sciences|September 21, 2023
Deep Learning Model for Tumor Type Prediction using Targeted Clinical Genomic Sequencing DataMadison Darmofal, Shalabh Suman, Gurnit Atwal, et al.
Pageof 28